Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014-2016 Outbreak in West Africa

Journal of Infectious Diseases

Volumn 218, Issue , 2018, Pages S287-S291

  Subissi, Lorenzo ^a   Keita, Mory ^b   Mesfin, Samuel ^b   Rezza, Giovanni ^c   Diallo, Boubacar ^b   Van Gucht, Steven ^a   Musa, Emmanuel Onuche ^b   Yoti, Zabulon ^b   Keita, Sakoba ^d   Djingarey, Mamoudou Harouna ^b   Diallo, Amadou Bailo ^b   Fall, Ibrahima Soce ^b  

^a Viral Diseases   (Belgium)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d National Agency for Health Security   (Guinea)

Author keywords

Ebola; re emergence; resurgence; survivor; transmission.

Indexed keywords

AFRICA; CONFERENCE PAPER; EBOLA HEMORRHAGIC FEVER; EPIDEMIC; GENE SEQUENCE; INFECTION RATE; INFECTION RISK; PRIORITY JOURNAL; RECURRENT INFECTION; SEXUAL TRANSMISSION; SURVIVOR; VIRUS GENOME; VIRUS TRANSMISSION; WEST AFRICA; BODY FLUID; EBOLAVIRUS; HUMAN; PATHOGENICITY; SPERM; VIROLOGY;

AFRICA, WESTERN; BODY FLUIDS; DISEASE OUTBREAKS; EBOLAVIRUS; EPIDEMICS; HEMORRHAGIC FEVER, EBOLA; HUMANS; SEMEN; SURVIVORS;

EID: 85053824718     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiy280     Document Type: Conference Paper

References (39)

1. World Health Organization. Ebola Situation Reports: Archive. 2016. Available at: http://www. who. int/csr/disease/ebola/situation-reports/archive/en/. Accessed 31 May 2018.
2. World Health Organization, US Centers for Disease Prevention and Control. Implementation and management of contact tracing for Ebola virus disease. 2015. Available at: http://apps. who. int/iris/bitstream/handle/10665/185258/ WHO-EVD-Guidance-Contact-15. 1-eng. pdf;jsessionid=82FCD9E1CD4724EE343A93F11D4FFBB4? sequence=1. Accessed 31 May 2018.
3. Keïta M, Conté F, Diallo B, et al. Lessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: A case series. BMC Infect Dis 2017; 17:304.
4. Quick J, Loman NJ, Duraffour S, et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 2016; 530:228-32.
5. Arias A, Watson SJ, Asogun D, et al. Rapid outbreak sequencing of Ebola virus in Sierra Leone identifies transmission chains linked to sporadic cases. Virus Evol 2016; 2:vew016.
6. Ladner JT, Wiley MR, Mate S, et al. Evolution and spread of Ebola virus in Liberia, 2014-2015. Cell Host Microbe 2015; 18:659-69.
7. World Health Organization. Criteria for declaring the end of the Ebola outbreak in Guinea, Liberia or Sierra Leone. 2015. Available at: http://www. who. int/csr/ disease/ebola/declaration-ebola-end/en/. Accessed 31 May 2018.
8. World Health Organization. Surveillance strategy during Phase 3 of the Ebola response. 2015. Available at: http://apps. who. int/iris/bitstream/handle/ 10665/192997/WHO-EVD-Guidance-Sur-15. 1-eng. pdf ?sequence=1. Accessed 31 May 2018.
9. Leroy EM, Baize S, Volchkov VE, et al. Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000; 355:2210-5.
10. Glynn JR, Bower H, Johnson S, et al. Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: A cross-sectional study using a new non-invasive assay for antibodies to Ebola virus. Lancet Infect Dis 2017; 17:645-53.
11. Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med 2015; 373:2448-54.
12. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola virus in ocular fluid during convalescence. N Engl J Med 2015; 372:2423-7.
13. Mora-Rillo M, Arsuaga M, Ramírez-Olivencia G, et al. Acute respiratory distress syndrome after convalescent plasma use: Treatment of a patient with Ebola virus disease contracted in Madrid, Spain. Lancet Respir Med 2015; 3:554-62.
14. Liddell AM, Davey RT Jr, Mehta AK, et al. Characteristics and clinical management of a cluster of 3 patients with Ebola virus disease, including the first domestically acquired cases in the United States. Ann Intern Med 2015; 163:81-90.
15. Sissoko D, Keïta M, Diallo B, et al. Ebola virus persistence in breast milk after no reported illness: A likely source of virus transmission from mother to child. Clin Infect Dis 2017; 64:513-16.
16. Vetter P, Fischer WA 2nd, Schibler M, Jacobs M, Bausch DG, Kaiser L. Ebola virus shedding and transmission: review of current evidence. J Infect Dis 2016; 214:177-84.
17. Nordenstedt H, Bah EI, de la Vega MA, et al. Ebola virus in breast milk in an Ebola virus-positive mother with twin babies, Guinea, 2015. Emerg Infect Dis 2016; 22:759-60.
18. Brainard J, Pond K, Hooper L, Edmunds K, Hunter P. Presence and persistence of Ebola or Marburg virus in patients and survivors: A rapid systematic review. PLoS Negl Trop Dis 2016; 10:e0004475.
19. Deen GF, Broutet N, Xu W, et al. Ebola RNA persistence in semen of Ebola virus disease survivors-final report. N Engl J Med 2017; 377:1428-37.
20. Grolla A, Jones SM, Fernando L, et al. The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg outbreak in Angola. PLoS Negl Trop Dis 2011; 5:e1183.
21. Sissoko D, Duraffour S, Kerber R, et al. Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: A longitudinal analysis and modelling study. Lancet Glob Health 2017; 5:e80-8.
22. Subtil F, Delaunay C, Keita AK, et al. Dynamics of Ebola RNA persistence in semen: A report from the postebogui cohort in Guinea. Clin Infect Dis 2017; 64:1788-90.
23. Soka MJ, Choi MJ, Baller A, et al. Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: An analysis of Ebola virus RNA results and behavioural data. Lancet Glob Health 2016; 4:e736-43.
24. Sow MS, Etard JF, Baize S, et al. New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors. J Infect Dis 2016; 214:1475-6.
25. Uyeki TM, Erickson BR, Brown S, et al. Ebola virus persistence in semen of male survivors. Clin Infect Dis 2016; 62:1552-5.
26. Rodriguez LL, De Roo A, Guimard Y, et al. Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis 1999; 179:S170-6.
27. Rowe AK, Bertolli J, Khan AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit. J Infect Dis 1999; 179:S28-35.
28. Martini GA, Schmidt HA. Spermatogenic transmission of the "Marburg virus" (causes of "Marburg simian disease"). Klin Wochenschr 1968; 46:398-400.
29. Christie A, Davies-Wayne GJ, Cordier-Lassalle T, et al. Possible sexual transmission of Ebola virus-Liberia, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:479-81.
30. Blackley DJ, Wiley MR, Ladner JT, et al. Reduced evolutionary rate in reemerged Ebola virus transmission chains. Sci Adv 2016; 2:e1600378.
31. Keita M, Duraffour S, Loman NJ, et al. Unusual Ebola virus chain of transmission, Conakry, Guinea, 2014-2015. Emerg Infect Dis 2016; 22:2149-52.
32. World Health Organization. Ebola Situation Report. 2015. Available at: http://apps. who. int/iris/bitstream/handle/10665/ 203828/ebolasitrep-23Dec2015-eng. pdf?sequence=1. Accessed 31 May 2018.
33. Nyenswah TG, Kateh F, Bawo L, et al. Ebola and its control in Liberia, 2014-2015. Emerg Infect Dis 2016; 22:169-77.
34. Alpren C, Sloan M, Boegler KA, et al. Notes from the field: Ebola virus disease cluster-Northern Sierra Leone, January 2016. MMWR Morb Mortal Wkly Rep 2016; 65:681-2.
35. Diallo B, Sissoko D, Loman NJ, et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 2016; 63:1353-6.
36. Allela L, Boury O, Pouillot R, et al. Ebola virus antibody prevalence in dogs and human risk. Emerg Infect Dis 2005; 11:385-90.
37. Bausch DG, Towner JS, Dowell SF, et al. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. J Infect Dis 2007; 196:S142-7.
38. Whitmer SLM, Ladner JT, Wiley MR, et al. Active Ebola virus replication and heterogeneous evolutionary rates in EVD survivors. Cell Rep 2018; 22:1159-68.
39. Kondé MK, Diop MK, Curtis MY, et al. Sex practices and awareness of Ebola virus disease among male survivors and their partners in Guinea. BMJ Glob Health 2017; 2:e000412.